Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials
Rik Ossenkoppele(University of California, Berkeley), Oskar Hansson(Lund University), Clifford R. Jack(Mayo Clinic), Joseph Therriault(Douglas Mental Health University Institute), Alexa Pichet Binette(Lund University), Divya Bali(Malmö University), James D. Doecke(Australian e-Health Research Centre), Randall J. Bateman(Washington University in St. Louis), Christopher C. Rowe(The University of Melbourne), Sebastian Palmqvist(Lund University), Erik Stomrud(Lund University), Wiesje M. van der Flier(University of Luxembourg), Erin M. Jonaitis(University of Wisconsin–Madison), Emma M. Coomans(Amsterdam Neuroscience), Elsmarieke van de Giessen(Amsterdam University Medical Centers), Azadeh Feizpour(The University of Melbourne), Ronald C. Petersen(Mayo Clinic), Niklas Mattsson(Lund University), Nesrine Rahmouni(McGill University), Colin L. Masters(Mental Health Research Institute), Gemma Salvadó(Lund University), Charlotte E. Teunissen(Amsterdam UMC Location Vrije Universiteit Amsterdam), Suzanne E. Schindler(Meharry Medical College), Sylvia Villeneuve(Douglas Mental Health University Institute), Shorena Janelidze(Lund University), Sterling C. Johnson, Pedro Rosa‐Neto(Montreal Neurological Institute and Hospital), Linda Karlsson(Lund University), Tammie L.S. Benzinger(Washington University in St. Louis), Heather J. Wiste(Mayo Clinic in Florida), Vincent Doré(Australian e-Health Research Centre)
Cited by 68
Related Papers
Mild cognitive impairment as a diagnostic entity
|Journal of Internal Medicine|2004|7.8k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k